HALO logo
halo search icon
Bausch + Lomb Corporation
Bausch + Lomb Corporation
BLCO · NYS

Bausch + Lomb Corporation

US$16.20

0.00 (0.00%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusEngulfing BullishFakey Shakey - Long (Realtime)HALO AllHALO GrowthHammer BullishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Bausch + Lomb Corporation Overview

BLCO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Neutral

Garp

Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About BLCO

icon

Website

Bausch + Lomb Corporation

icon

Telephone

1.905.695.7700

icon

Address

520 Applewood Crescent, Vaughan, ON L4K 4B4

Description

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

BLCO Price Chart

Key Stats

Market Cap

US$5.78B

PE

33.40

EV/EBITDA

17.7

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 10.99 - 18.92

Trade Value (12mth)

US$2,006,242.00

1 week

0.68%

1 month

1%

YTD

-2.29%

1 year

44.77%

All time high

21.95

Key Fundamentals

EPS 3 yr Growth

-6050.30%

EBITDA Margin

11.90%

Operating Cashflow

$283m

Free Cash Flow Return

2.50%

ROIC

-3.10%

Interest Coverage

1.40

Quick Ratio

1.00

Other Data

Shares Outstanding (Fully Diluted)

355m

HALO Sector

Healthcare

Next Company Report Date

24-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BLCO Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
30 April 26
30 April 26
29 April 26

BLCO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.74-0.9-1.02locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.74-0.9-1.02locklocklock
Growth
%locklocklocklock-4,438.0-21.5-12.9locklocklock
PE
Xlocklocklocklock21.928.133.4locklocklock
EV/EBITDA
Xlocklocklocklock17.51717.7locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Bausch + Lomb Corporation (BLCO:NYS)?
Halo FAQ
The current share price of Bausch + Lomb Corporation (BLCO:NYS) is USD$16.20.
What is the 52-week high share price for Bausch + Lomb Corporation (BLCO:NYS)?
Halo FAQ
The 52-week high share price for Bausch + Lomb Corporation (BLCO:NYS) is USD$18.92.
What is the 52-week low share price for Bausch + Lomb Corporation (BLCO:NYS)?
Halo FAQ
The 52-week low share price for Bausch + Lomb Corporation (BLCO:NYS) is USD$10.99.
What is the dividend yield for Bausch + Lomb Corporation (BLCO:NYS)?
Halo FAQ
Bausch + Lomb Corporation (BLCO:NYS) does not pay a dividend.
What was Bausch + Lomb Corporation (BLCO:NYS) last dividend payment?
Halo FAQ
Bausch + Lomb Corporation (BLCO:NYS) does not pay a dividend.
What is the franking level for Bausch + Lomb Corporation (BLCO:NYS)?
Halo FAQ
Bausch + Lomb Corporation (BLCO:NYS) has a franking level of 0.00%.
In which sector is Bausch + Lomb Corporation (BLCO:NYS) classified?
Halo FAQ
Bausch + Lomb Corporation (BLCO:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Bausch + Lomb Corporation (BLCO:NYS)?
Halo FAQ
The current P/E ratio for Bausch + Lomb Corporation (BLCO:NYS) is 33.40.

See beyond the curve.

One solution for research, investing and portfolio management.